Efficacy Outcomes of Fecal Microbiota, Live-jslm in Preventing Recurrent Clostridioides difficile Infection from Seven Clinical Studies
Abstract Clostridioides difficile infection (CDI) is one of the most common healthcare-associated infections in the US, and recurrence remains a major clinical challenge, as standard-of-care antibiotics fail to prevent recurrence in up to one-third of cases. Fecal microbiota, live-jslm (RBL) is the...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Adis, Springer Healthcare
2026-06-01
|
| Seri Bilgileri: | Infectious Diseases and Therapy |
| Konular: | |
| Online Erişim: | https://doi.org/10.1007/s40121-026-01374-9 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|